The emergence of therapeutic agents like semaglutide and tirzepatide has significantly altered the approach to managing type 2 diabetes and promoting weight loss. While both drugs share a shared mechanism of action – mimicking the effects of the natural hormone GLP-1 – tirzepatide possesses a distinct advantage: it’s a dual activator, targeti